MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

08 Aug 2024 Evaluate
The June 2024 quarter revenue stood at Rs. 334.22 millions, up 7.38% as compared to Rs. 311.25 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 40.54  millions from Rs. 41.88 millions ,decline by -3.20%.Operating profit surged to 64.31 millions from the corresponding previous quarter of 62.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 334.22 311.25 7.38 334.22 311.25 7.38 1315.99 1177.84 11.73
Other Income 32.12 9.78 228.43 32.12 9.78 228.43 61.89 45.98 34.60
PBIDT 64.31 62.17 3.44 64.31 62.17 3.44 265.06 217.71 21.75
Interest 4.90 3.79 29.29 4.90 3.79 29.29 19.08 9.85 93.71
PBDT 59.41 58.38 1.76 59.41 58.38 1.76 245.98 207.86 18.34
Depreciation 3.49 2.57 35.80 3.49 2.57 35.80 12.44 13.37 -6.96
PBT 55.92 55.81 0.20 55.92 55.81 0.20 233.54 194.49 20.08
TAX 15.38 13.93 10.41 15.38 13.93 10.41 57.79 37.32 54.85
Deferred Tax 2.73 -5.93 -146.04 2.73 -5.93 -146.04 -5.86 -4.66 25.75
PAT 40.54 41.88 -3.20 40.54 41.88 -3.20 175.75 157.17 11.82
Equity 160.82 155.82 3.21 160.82 155.82 3.21 160.82 155.82 3.21
PBIDTM(%) 19.24 19.97 -3.67 19.24 19.97 -3.67 20.14 18.48 8.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..